Navigation Links
ChemGenex's omacetaxine may provide first viable treatment option for highly resistant form of CML
Date:6/1/2009

MELBOURNE, Australia, and MENLO PARK, California U.S.A. (June 1st, 2009) ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) announced that the latest data from its pivotal study of omacetaxine in patients with T315I-positive chronic myeloid leukemia (CML) was the subject of an oral presentation and discussion today at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida. The open label Phase 2/3 study (CGX-635-CML-202) investigated the use of omacetaxine, administered subcutaneously in CML patients who had failed imatinib and who have the highly drug resistant T315I kinase domain mutation.

Dr. Jorge Cortes, MD, Professor of Medicine and Deputy Chair in the Department of Leukemia at The University of Texas, MD Anderson Cancer Center, a lead investigator in the study, presented the data. Dr. Cortes said, "It appears that omacetaxine was well tolerated in this study and durable hematological and cytogenetic responses were observed in some CML patients with the T315I mutation." He added that "Several novel drugs have already been investigated in this difficult-to-treat population, but they have not had a reasonable risk:benefit ratio. These results suggest that omacetaxine may represent the first viable treatment option for this population of patients who currently have no established treatment options."

Data were presented from 66 patients: 40 in chronic phase, 16 in accelerated phase and 10 in blast phase. Highlights of the data were:

Chronic phase patients

  • Complete hematologic response (CHR) rate of 85% with a median response duration 8.9 months
  • Major cytogenetic response (MCyR) rate of 15% with a median response duration 6.1 months

Accelerated phase patients

  • CHR rate of 31% with a median duration 4.1 months
  • MCyR rate of 6% with a median response duration 1.8 months

Blast phase patients
'/>"/>

Contact: Joan Kureczka
Joan@kureczka-martin.com
415-821-2413
Kureczka/Martin Associates
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
4. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
5. USAID Provides Additional Wildfire Assistance to Greece
6. MinuteClinic Becomes Participating Provider with Assurant Health
7. Over 500,000 Health Care Providers Now Cutting Costs, Saving Time Through CAQH Administrative Simplification Initiative
8. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
9. New knock-out gene model provides molecular clues to breast cancer
10. Area Health Care Providers Announce Plans to Integrate Services
11. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... TX (PRWEB) May 23, 2013 Dr. Damon ... patients who suffer from gum disease a revolutionary new treatment ... are actually millions of Americans who suffer from periodontal disease, ... arrange for treatment. Dr. Huffman is hoping that LANAP ... periodontal disease treatment. , Periodontal disease can ...
(Date:5/23/2013)... Jersey (PRWEB) May 23, 2013 If ... suffering from irritable bowel syndrome (IBS), the food spread ... your holiday fun. , “While hot dogs and ice ... during the warm weather months, IBS sufferers often feel ... Deborah Sokol, MD, a gastroenterologist with Lourdes Medical Associates. ...
(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Today, ... employer mandate . Zane Benefits, which provides comprehensive ... is the leader in defined contribution plans ... care reform, a common question from employees is “does ... Zane Benefits’ website, not necessarily. The health care reform ...
(Date:5/23/2013)... Funeral Financials is encouraging American’s to donate ... EOD Memorial Foundation Funeral Financials considers EOD’s from ... the war. , According to MarineEOD.com, bomb disposal ... U.S. was even at war. True EOD’s of ... Explosive Ordnance Disposal Badge. EOD technicians have been through ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Onlinefitnessreview.com recently ... Blast Diet to determine what makes this diet work ... published review highlights three main components of the program: ... a positive mindset and the personal motivation that is ... every 7 days to keep the metabolism rate in ...
Breaking Medicine News(10 mins):Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:Zane Benefits Publishes New Information on the Employer Mandate 2Health News:Zane Benefits Publishes New Information on the Employer Mandate 3Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2
... Philadelphia, PA, 6 April 2010 - Attention-deficit/hyperactivity disorder (ADHD) ... affecting children and adolescents. Children with ADHD are excessively ... and in school. Problems inhibiting behavior are a common ... treated with stimulant medications, behavioral approaches or a combination ...
... ... to promote organic seed research and conserve crop genetic diversity – ultimately ensuring a ... ... The CLIF BAR Family Foundation today announced a $500,000 grant to promote organic seed ...
... more children today are surviving cancer than ever before, young ... a decade less, on average, than the general population, according ... School of Public Health. Depending on the type of ... years to more than 17 years, the scientists report in ...
... from the Department of Exercise and Sports Sciences, University ... involving both men, women and children, who were divided ... the studies are so remarkable that the Scandinavian ... publishing a special edition issue entitled "Football for Health" ...
... 65 percent in U.S., study finds , TUESDAY, April ... intentional abuse of prescription sedatives, tranquilizers and other painkilling ... research reveals. , Hospital stays from an unintentional overdose ... (such as Valium and Ativan) jumped 37 percent between ...
... ... III in Webinar Series on Opportunities for Improvement in Various Stages of the RN ... ... human capital research firm, will host a webinar titled “When Engagement Isn’t Enough: Retaining ...
Cached Medicine News:Health News:Synergy between behavioral and pharmacologic interventions for ADHD 2Health News:CLIF BAR Family Foundation Commits $500,000 to Protect and Promote Organic Seed and Farming 2Health News:Childhood cancer survivors may face shortened lifespan, study reveals 2Health News:Childhood cancer survivors may face shortened lifespan, study reveals 3Health News:Childhood cancer survivors may face shortened lifespan, study reveals 4Health News:Scientists: Soccer improves health, fitness and social abilities 2Health News:Scientists: Soccer improves health, fitness and social abilities 3Health News:Scientists: Soccer improves health, fitness and social abilities 4Health News:Prescription Drug Abuse Sending More to Hospitals 2Health News:Prescription Drug Abuse Sending More to Hospitals 3Health News:Morehead Presents Webinar on ,“When Engagement Isn't Enough: Retaining RNs”, 2
(Date:5/23/2013)... 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the 2013 Life Science Firm of the Year by the ... was honored at the TCM,s 25 th Annual Tech ... The Tech Awards Celebration recognizes the leaders and innovators in ... and the surrounding regions. "We ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... DIEGO , May 23, 2013 Neurocrine Biosciences, ... Kevin Gorman , President and Chief Executive Officer ... 38 th Annual dbAccess Health Care Conference in Boston.   ... May 30 at 11:20 a.m. Eastern Time / 8:20 a.m. ... accessed on the Company,s website at http://www.neurocrine.com . ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... April 29 Today is an exciting day for ... ones who are profoundly affected. Today a new prostate cancer treatment option, ... , , ... excited to see this innovative treatment option made available for patients with ...
... South Korea , April 29 OrbusNeich today announced that ... final 12-month clinical results of the global e-HEALING Registry confirmed that the ... in this high-risk patient group. , ... The data were presented by Dr. Andres Iniguez , M.D., ...
Cached Medicine Technology:Advanced Prostate Cancer Patients Finally Have Another Option 2OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients 2OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients 3
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures....
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... to disintegrate renal and ureteral ... technology in a compact design ... and affordable lithotripsy system. The ... of clinical results for both ...
Medicine Products: